We are looking for children and teens 2–17 years of age to join a Crohn’s disease clinical trial to help us discover more about treating moderate to severe Crohn’s disease. If you are looking for a potential new treatment option for moderate to severe Crohn’s disease or moderately to severely active ulcerative colitis (including associated symptoms such as recurrent diarrhea, reduced appetite, bloody stool, weight loss and/or anemia), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the IBD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child is eligible.
